David P. Schenkein, M.D.

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get REGN alerts

About David P. Schenkein, M.D.

David P. Schenkein, M.D. is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN) since September 8, 2023. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.

Affiliation history

Regeneron Pharmaceuticals, Inc. (REGN)
Board Member

SEC 8-K

Current
2023-09-08–present

Company network

Regeneron Pharmaceuticals, Inc.

REGN

Current role

Biotechnology · Healthcare

Board Member

2023-09-08–present

Leadership on record at Regeneron Pharmaceuticals, Inc.

George D. Yancopoulos, M.D., Ph.D. Chairman
Leonard S. Schleifer, M.D., Ph.D. Chairman
Joseph J. LaRosa General Counsel
Christine A. Poon Board Member
Craig B. Thompson, M.D. Board Member
David P. Schenkein Board Member
Huda Y. Zoghbi, M.D. Board Member
Joseph L. Goldstein, M.D. Board Member
Kathryn Guarini Board Member
Kathryn Guarini, Ph.D. Board Member

Recent activity

No call appearances or filed executive changes recorded yet.